Related content

PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS

By Adeli Mehdi Mohammad G.   Eichner Brian H.   Thornburg Courtney   Williams Larry  

Pediatric Hematology and Oncology, Vol. 26, Iss. 8, 2009-11 ,pp. : 566-572

Informa Healthcare

Access to resources Recommend Favorite

A therapy-refractory neonatal auto-immune thrombocytopenia treated with anti-D

By Gaedicke Gerhard   Cremer Malte   Meyer Oliver   Salama Abdulgabar  

European Journal of Pediatrics, Vol. 163, Iss. 3, 2004-03 ,pp. : 183-184

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai

By Sun Li   Xu Hong   Shen Qian   Cao Qi   Rao Jia   Liu Hai-Mei   Fang Xiao-Yan   Zhou Li-Jun  

World Journal of Pediatrics, Vol. 10, Iss. 1, 2014-02 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab-induced long-term remission in two children with SLE

By Jansson Annette   Wintergerst Uwe   Renner Ellen   Belohradsky Bernd  

European Journal of Pediatrics, Vol. 166, Iss. 2, 2007-02 ,pp. : 177-181

Springer Publishing Company

Access to resources Recommend Favorite

Anti-CD20 Monoclonal Antibody (Rituximab) for Therapy of Mediastinal CD20-Positive Large B-Cell Non-Hodgkin Lymphoma with a Local Tumor Extension into the Lung of a 10-Year-Old Girl

By Čulic´ Srdjana   Čulic´ Vida   Armanda Visnja   Kuljiš Dubravka   Pešutic´-Pisac Valdi   Jankovic´ Stipan  

Pediatric Hematology and Oncology, Vol. 20, Iss. 4, 2003-06 ,pp. : 339-344

Informa Healthcare

Access to resources Recommend Favorite